Molecular pathogenesis of Parkinson's disease
Identifieur interne : 001481 ( Main/Corpus ); précédent : 001480; suivant : 001482Molecular pathogenesis of Parkinson's disease
Auteurs : Sonia Gandhi ; Nicholas W. WoodSource :
- Human Molecular Genetics [ 0964-6906 ] ; 2005-09-15.
Abstract
Parkinson's disease (PD) is a common and incurable neurodegenerative disease, affecting 1% of the population over the age of 65. Despite a well-described clinical and pathological phenotype, the molecular mechanisms which lead to neurodegeneration remain elusive. However, there is a wealth of evidence from both toxin based models and genetic based models, which suggest a major etiologic role for mitochondrial dysfunction, protein aggregation, the ubiquitin–proteasome system and kinase signalling pathways in the pathogenesis of PD. Ultimately, an understanding of the molecular events which precipitate neurodegeneration in idiopathic PD will enable the development of targeted and effective therapeutic strategies. We review the latest evidence for the proposed molecular processes and discuss their relevance to the pathogenesis of sporadic PD.
Url:
DOI: 10.1093/hmg/ddi308
Links to Exploration step
ISTEX:12B930FAF6DA420D468E73F65C95B7BBDBCAA100Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Molecular pathogenesis of Parkinson's disease</title><author><name sortKey="Gandhi, Sonia" sort="Gandhi, Sonia" uniqKey="Gandhi S" first="Sonia" last="Gandhi">Sonia Gandhi</name><affiliation><mods:affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London</mods:affiliation></affiliation></author><author><name sortKey="Wood, Nicholas W" sort="Wood, Nicholas W" uniqKey="Wood N" first="Nicholas W." last="Wood">Nicholas W. Wood</name><affiliation><mods:affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: n.wood@ion.ucl.ac.uk</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:12B930FAF6DA420D468E73F65C95B7BBDBCAA100</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1093/hmg/ddi308</idno><idno type="url">https://api.istex.fr/document/12B930FAF6DA420D468E73F65C95B7BBDBCAA100/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001481</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Molecular pathogenesis of Parkinson's disease</title><author><name sortKey="Gandhi, Sonia" sort="Gandhi, Sonia" uniqKey="Gandhi S" first="Sonia" last="Gandhi">Sonia Gandhi</name><affiliation><mods:affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London</mods:affiliation></affiliation></author><author><name sortKey="Wood, Nicholas W" sort="Wood, Nicholas W" uniqKey="Wood N" first="Nicholas W." last="Wood">Nicholas W. Wood</name><affiliation><mods:affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: n.wood@ion.ucl.ac.uk</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Human Molecular Genetics</title><title level="j" type="abbrev">Hum. Mol. Genet.</title><idno type="ISSN">0964-6906</idno><idno type="eISSN">1460-2083</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="2005-09-15">2005-09-15</date><biblScope unit="volume">14</biblScope><biblScope unit="issue">18</biblScope><biblScope unit="page" from="2749">2749</biblScope><biblScope unit="page" to="2755">2755</biblScope></imprint><idno type="ISSN">0964-6906</idno></series><idno type="istex">12B930FAF6DA420D468E73F65C95B7BBDBCAA100</idno><idno type="DOI">10.1093/hmg/ddi308</idno><idno type="href">ddi308</idno><idno type="local">ddi308</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0964-6906</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is a common and incurable neurodegenerative disease, affecting 1% of the population over the age of 65. Despite a well-described clinical and pathological phenotype, the molecular mechanisms which lead to neurodegeneration remain elusive. However, there is a wealth of evidence from both toxin based models and genetic based models, which suggest a major etiologic role for mitochondrial dysfunction, protein aggregation, the ubiquitin–proteasome system and kinase signalling pathways in the pathogenesis of PD. Ultimately, an understanding of the molecular events which precipitate neurodegeneration in idiopathic PD will enable the development of targeted and effective therapeutic strategies. We review the latest evidence for the proposed molecular processes and discuss their relevance to the pathogenesis of sporadic PD.</div></front></TEI><istex><corpusName>oup</corpusName><author><json:item><name>Sonia Gandhi</name><affiliations><json:string>Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London</json:string></affiliations></json:item><json:item><name>Nicholas W. Wood</name><affiliations><json:string>Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London</json:string><json:string>E-mail: n.wood@ion.ucl.ac.uk</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>ARTICLES</value></json:item></subject><language><json:string>eng</json:string></language><abstract>Parkinson's disease (PD) is a common and incurable neurodegenerative disease, affecting 1% of the population over the age of 65. Despite a well-described clinical and pathological phenotype, the molecular mechanisms which lead to neurodegeneration remain elusive. However, there is a wealth of evidence from both toxin based models and genetic based models, which suggest a major etiologic role for mitochondrial dysfunction, protein aggregation, the ubiquitin–proteasome system and kinase signalling pathways in the pathogenesis of PD. Ultimately, an understanding of the molecular events which precipitate neurodegeneration in idiopathic PD will enable the development of targeted and effective therapeutic strategies. We review the latest evidence for the proposed molecular processes and discuss their relevance to the pathogenesis of sporadic PD.</abstract><qualityIndicators><score>6.383</score><pdfVersion>1.2</pdfVersion><pdfPageSize>610 x 795 pts</pdfPageSize><refBibsNative>false</refBibsNative><keywordCount>1</keywordCount><abstractCharCount>851</abstractCharCount><pdfWordCount>4967</pdfWordCount><pdfCharCount>32440</pdfCharCount><pdfPageCount>7</pdfPageCount><abstractWordCount>118</abstractWordCount></qualityIndicators><title>Molecular pathogenesis of Parkinson's disease</title><genre><json:string>research-article</json:string></genre><host><volume>14</volume><pages><last>2755</last><first>2749</first></pages><issn><json:string>0964-6906</json:string></issn><issue>18</issue><genre></genre><language><json:string>unknown</json:string></language><eissn><json:string>1460-2083</json:string></eissn><title>Human Molecular Genetics</title></host><categories><wos><json:string>BIOCHEMISTRY & MOLECULAR BIOLOGY</json:string><json:string>GENETICS & HEREDITY</json:string></wos></categories><publicationDate>2005</publicationDate><copyrightDate>2005</copyrightDate><doi><json:string>10.1093/hmg/ddi308</json:string></doi><id>12B930FAF6DA420D468E73F65C95B7BBDBCAA100</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/12B930FAF6DA420D468E73F65C95B7BBDBCAA100/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/12B930FAF6DA420D468E73F65C95B7BBDBCAA100/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/12B930FAF6DA420D468E73F65C95B7BBDBCAA100/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Molecular pathogenesis of Parkinson's disease</title><respStmt xml:id="ISTEX-API" resp="Références bibliographiques récupérées via GROBID" name="ISTEX-API (INIST-CNRS)"></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Oxford University Press</publisher><availability><p>OUP</p></availability><date>2005-08-26</date></publicationStmt><notesStmt><note>*To whom correspondence should be addressed. Email: n.wood@ion.ucl.ac.uk</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Molecular pathogenesis of Parkinson's disease</title><author><persName><forename type="first">Sonia</forename><surname>Gandhi</surname></persName><affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London</affiliation></author><author><persName><forename type="first">Nicholas W.</forename><surname>Wood</surname></persName><email>n.wood@ion.ucl.ac.uk</email><affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London</affiliation></author></analytic><monogr><title level="j">Human Molecular Genetics</title><title level="j" type="abbrev">Hum. Mol. Genet.</title><idno type="pISSN">0964-6906</idno><idno type="eISSN">1460-2083</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="2005-09-15"></date><biblScope unit="volume">14</biblScope><biblScope unit="issue">18</biblScope><biblScope unit="page" from="2749">2749</biblScope><biblScope unit="page" to="2755">2755</biblScope></imprint></monogr><idno type="istex">12B930FAF6DA420D468E73F65C95B7BBDBCAA100</idno><idno type="DOI">10.1093/hmg/ddi308</idno><idno type="href">ddi308</idno><idno type="local">ddi308</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2005-08-26</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Parkinson's disease (PD) is a common and incurable neurodegenerative disease, affecting 1% of the population over the age of 65. Despite a well-described clinical and pathological phenotype, the molecular mechanisms which lead to neurodegeneration remain elusive. However, there is a wealth of evidence from both toxin based models and genetic based models, which suggest a major etiologic role for mitochondrial dysfunction, protein aggregation, the ubiquitin–proteasome system and kinase signalling pathways in the pathogenesis of PD. Ultimately, an understanding of the molecular events which precipitate neurodegeneration in idiopathic PD will enable the development of targeted and effective therapeutic strategies. We review the latest evidence for the proposed molecular processes and discuss their relevance to the pathogenesis of sporadic PD.</p></abstract></profileDesc><revisionDesc><change when="2005-08-26">Created</change><change when="2005-09-15">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-3-14">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/12B930FAF6DA420D468E73F65C95B7BBDBCAA100/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus oup" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="US-ASCII"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType><istex:document><article xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="hwp">hmg</journal-id><journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id><journal-id journal-id-type="publisher-id">hmg</journal-id><journal-title>Human Molecular Genetics</journal-title><abbrev-journal-title abbrev-type="publisher">Hum. Mol. Genet.</abbrev-journal-title><issn pub-type="ppub">0964-6906</issn><issn pub-type="epub">1460-2083</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="other">ddi308</article-id><article-id pub-id-type="doi">10.1093/hmg/ddi308</article-id><article-categories><subj-group subj-group-type="heading"><subject>ARTICLES</subject></subj-group></article-categories><title-group><article-title>Molecular pathogenesis of Parkinson's disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gandhi</surname><given-names>Sonia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wood</surname><given-names>Nicholas W.</given-names></name><xref rid="COR1">*</xref></contrib><aff>Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London</aff></contrib-group><author-notes><corresp id="COR1"><label>*</label>To whom correspondence should be addressed. Email: <ext-link xlink:href="n.wood@ion.ucl.ac.uk" ext-link-type="email">n.wood@ion.ucl.ac.uk</ext-link></corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>08</month><year>2005</year></pub-date><pub-date pub-type="ppub"><day>15</day><month>September</month><year>2005</year></pub-date><volume>14</volume><issue>18</issue><fpage>2749</fpage><lpage>2755</lpage><history><date date-type="accepted"><day>6</day><month>08</month><year>2005</year></date><date date-type="received"><day>2</day><month>08</month><year>2005</year></date></history><permissions><copyright-statement>© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org</copyright-statement><copyright-year>2005</copyright-year></permissions><self-uri content-type="arthw-pdf" xlink:href="ddi308"></self-uri><abstract xml:lang="en"><p>Parkinson's disease (PD) is a common and incurable neurodegenerative disease, affecting 1% of the population over the age of 65. Despite a well-described clinical and pathological phenotype, the molecular mechanisms which lead to neurodegeneration remain elusive. However, there is a wealth of evidence from both toxin based models and genetic based models, which suggest a major etiologic role for mitochondrial dysfunction, protein aggregation, the ubiquitin–proteasome system and kinase signalling pathways in the pathogenesis of PD. Ultimately, an understanding of the molecular events which precipitate neurodegeneration in idiopathic PD will enable the development of targeted and effective therapeutic strategies. We review the latest evidence for the proposed molecular processes and discuss their relevance to the pathogenesis of sporadic PD.</p></abstract><custom-meta-wrap><custom-meta><meta-name>hwp-legacy-fpage</meta-name><meta-value>2749</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>15 September 2005</meta-value></custom-meta><custom-meta><meta-name>hwp-legacy-dochead</meta-name><meta-value>Article</meta-value></custom-meta></custom-meta-wrap></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Molecular pathogenesis of Parkinson's disease</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Molecular pathogenesis of Parkinson's disease</title></titleInfo><name type="personal"><namePart type="given">Sonia</namePart><namePart type="family">Gandhi</namePart><affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Nicholas W.</namePart><namePart type="family">Wood</namePart><affiliation>Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London</affiliation><affiliation>E-mail: n.wood@ion.ucl.ac.uk</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="research-article"></genre><originInfo><publisher>Oxford University Press</publisher><dateIssued encoding="w3cdtf">2005-09-15</dateIssued><dateCreated encoding="w3cdtf">2005-08-26</dateCreated><copyrightDate encoding="w3cdtf">2005</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Parkinson's disease (PD) is a common and incurable neurodegenerative disease, affecting 1% of the population over the age of 65. Despite a well-described clinical and pathological phenotype, the molecular mechanisms which lead to neurodegeneration remain elusive. However, there is a wealth of evidence from both toxin based models and genetic based models, which suggest a major etiologic role for mitochondrial dysfunction, protein aggregation, the ubiquitin–proteasome system and kinase signalling pathways in the pathogenesis of PD. Ultimately, an understanding of the molecular events which precipitate neurodegeneration in idiopathic PD will enable the development of targeted and effective therapeutic strategies. We review the latest evidence for the proposed molecular processes and discuss their relevance to the pathogenesis of sporadic PD.</abstract><note type="author-notes">*To whom correspondence should be addressed. Email: n.wood@ion.ucl.ac.uk</note><relatedItem type="host"><titleInfo><title>Human Molecular Genetics</title></titleInfo><titleInfo type="abbreviated"><title>Hum. Mol. Genet.</title></titleInfo><genre type="Journal">journal</genre><identifier type="ISSN">0964-6906</identifier><identifier type="eISSN">1460-2083</identifier><identifier type="PublisherID">hmg</identifier><identifier type="PublisherID-hwp">hmg</identifier><identifier type="PublisherID-nlm-ta">Hum Mol Genet</identifier><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><detail type="issue"><caption>no.</caption><number>18</number></detail><extent unit="pages"><start>2749</start><end>2755</end></extent></part></relatedItem><identifier type="istex">12B930FAF6DA420D468E73F65C95B7BBDBCAA100</identifier><identifier type="DOI">10.1093/hmg/ddi308</identifier><identifier type="href">ddi308</identifier><identifier type="local">ddi308</identifier><accessCondition type="use and reproduction" contentType="copyright">© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org</accessCondition><recordInfo><recordContentSource>OUP</recordContentSource></recordInfo></mods></metadata><covers><json:item><original>true</original><mimetype>image/tiff</mimetype><extension>tiff</extension><uri>https://api.istex.fr/document/12B930FAF6DA420D468E73F65C95B7BBDBCAA100/covers/tiff</uri></json:item><json:item><original>true</original><mimetype>text/html</mimetype><extension>html</extension><uri>https://api.istex.fr/document/12B930FAF6DA420D468E73F65C95B7BBDBCAA100/covers/html</uri></json:item></covers><annexes><json:item><original>true</original><mimetype>image/jpeg</mimetype><extension>jpeg</extension><uri>https://api.istex.fr/document/12B930FAF6DA420D468E73F65C95B7BBDBCAA100/annexes/jpeg</uri></json:item><json:item><original>true</original><mimetype>image/gif</mimetype><extension>gif</extension><uri>https://api.istex.fr/document/12B930FAF6DA420D468E73F65C95B7BBDBCAA100/annexes/gif</uri></json:item></annexes><enrichments><istex:catWosTEI uri="https://api.istex.fr/document/12B930FAF6DA420D468E73F65C95B7BBDBCAA100/enrichments/catWos"><teiHeader><profileDesc><textClass><classCode scheme="WOS">BIOCHEMISTRY & MOLECULAR BIOLOGY</classCode><classCode scheme="WOS">GENETICS & HEREDITY</classCode></textClass></profileDesc></teiHeader></istex:catWosTEI></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001481 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001481 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:12B930FAF6DA420D468E73F65C95B7BBDBCAA100
|texte= Molecular pathogenesis of Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |